Reporting Guidelines

SEER Program Coding Manual

The 2023 manual is to be used for cases diagnosed January 1, 2023 and forward.

Hematopoietic Project

Data collection rules for hematopoietic and lymphoid neoplasms for 2010+.

Solid Tumor Rules

The 2024 Update includes changes that apply to cases diagnosed January 1, 2024 and after.

COVID-19 Abstraction Guidance

Technical guidance regarding the implementation of COVID-19 data abstraction.

Tools & Software

Glossary for Registrars

Use of terms, alternate names, abstractor notes, primary site and histology.

SEER*Rx - Drug Database

One-step lookup for coding oncology drug and regimen treatment categories.

SEER Abstracting Tool (SEER*Abs)

Used to collect and store data abstracted from medical records.

SEER Data Management System (SEER*DMS)

Supports all core cancer registry functions.

Cancer PathCHART - Tumor Site-Histology Surveillance Standards Initiative

Cancer Pathology Coding Histology And Registration Terminology (Cancer PathCHART) is a first-of-its-kind initiative in North America and around the world to update standards for tumor site, histology, and behavior code combinations and associated terminology. 


Registrar Staging Assistant

Intended for use by cancer registrars to help assign Extent of Disease (EOD) 2018.

Summary Stage 2018

The most basic way of categorizing how far a cancer has spread from its point of origin.

Extent of Disease 2018

Resources including the EOD General Instructions and the EOD Consolidation Manual.

Pediatric Data Collection System and Staging Manual

Staging and site-specific data item (SSDI) Information for Pediatric and Adolescent/Young Adult (AYA) populations.


Becoming a Cancer Registry Professional

Frequently asked questions and resources on becoming a CTR/ODS.

SEER Training Web Site

Web-based training modules for cancer registration and surveillance.

SEER*EducateExternal Web Site Policy

Online training platform for cancer registry professionals.